SalioGen Therapeutics
Quinner Baltazar has a wealth of work experience, beginning in 2002 with San Miguel Brewery as a QC Chemist/Field Assessor. In 2008, they joined Analytical Research Labs as a Research Chemist. In 2009, they moved to Qualitest Pharmaceuticals as a Validation Chemist, and in 2010 they became a Senior Research Associate at Vertex Pharmaceuticals. In 2013, they joined Alkermes as a Scientist II, and in 2015 they became the CEO of MyCyberGenie, an outsourcing industry leader. In 2016, they joined Moderna Therapeutics as a Senior Manager of Analytical Development, and in 2020 they became an Associate Director at Cogent Biosciences. Quinner currently holds the same position at SalioGen Therapeutics.
Quinner Baltazar completed their high school education at MSU- Science High School from 1993 to 1997, earning a High School degree in Science. Quinner then attended the University of San Carlos from 1997 to 2001, earning a Bachelor's Degree in Chemistry. Lastly, they attended The University of Toledo from 2005 to 2007, earning a Masters Degree in Analytical Chemistry.